253 related articles for article (PubMed ID: 35415876)
1. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer.
Gao Y; Zhang N; Zeng Z; Wu Q; Jiang X; Li S; Sun W; Zhang J; Li Y; Li J; He F; Huang Z; Zhang J; Gong Y; Xie C
Clin Transl Med; 2022 Apr; 12(4):e792. PubMed ID: 35415876
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PCAT1 Interacts with DKC1 to Regulate Proliferation, Invasion and Apoptosis in NSCLC Cells via the VEGF/AKT/Bcl2/Caspase9 Pathway.
Liu SY; Zhao ZY; Qiao Z; Li SM; Zhang WN
Cell Transplant; 2021; 30():963689720986071. PubMed ID: 33461333
[TBL] [Abstract][Full Text] [Related]
3. GATA6 activated long non-coding RNA PCAT1 maintains stemness of non-small cell lung cancer by mediating FRK.
Zang Q; Xu L; Li J; Jia H
J BUON; 2020; 25(5):2371-2381. PubMed ID: 33277858
[TBL] [Abstract][Full Text] [Related]
4. Increased activation of cGAS-STING pathway enhances radiosensitivity of non-small cell lung cancer cells.
Xue A; Shang Y; Jiao P; Zhang S; Zhu C; He X; Feng G; Fan S
Thorac Cancer; 2022 May; 13(9):1361-1368. PubMed ID: 35429143
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p.
Wu W; Zhao Y; Gao E; Li Y; Guo X; Zhao T; He W; Zhang H
J Cell Mol Med; 2020 Jan; 24(1):441-450. PubMed ID: 31721438
[TBL] [Abstract][Full Text] [Related]
6. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
[TBL] [Abstract][Full Text] [Related]
8. SOX2-induced upregulation of lncRNA LINC01561 promotes non-small-cell lung carcinoma progression by sponging miR-760 to modulate SHCBP1 expression.
Gao W; Qi CQ; Feng MG; Yang P; Liu L; Sun SH
J Cell Physiol; 2020 Oct; 235(10):6684-6696. PubMed ID: 32003010
[TBL] [Abstract][Full Text] [Related]
9. An overview of the crosstalk between YAP and cGAS-STING signaling in non-small cell lung cancer: it takes two to tango.
Hao F
Clin Transl Oncol; 2022 Sep; 24(9):1661-1672. PubMed ID: 35377059
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
11. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A; Wang J
DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
13. Loss of STING expression is prognostic in non-small cell lung cancer.
Lohinai Z; Dora D; Caldwell C; Rivard CJ; Suda K; Yu H; Rivalland G; Ellison K; Rozeboom L; Dziadziuszko R; Mitchell P; John T; Millan IS; Ren S; Hirsch FR
J Surg Oncol; 2022 May; 125(6):1042-1052. PubMed ID: 35099823
[TBL] [Abstract][Full Text] [Related]
14. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
16. MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axis.
Fan H; Yuan J; Li Y; Jia Y; Li J; Wang X; Li X
Cell Death Dis; 2021 Jan; 12(1):128. PubMed ID: 33500406
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
19. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
[TBL] [Abstract][Full Text] [Related]
20. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer.
Yan X; Yao C; Fang C; Han M; Gong C; Hu D; Shen W; Wang L; Li S; Zhu S
Int J Biol Sci; 2022; 18(2):585-598. PubMed ID: 35002511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
